Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02187302
Title CRLX101 in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cerulean Pharma Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego La Jolla California 92093 United States Details
David Geffen School of Medicine UCLA Los Angeles California 90024 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Emory University Atlanta Georgia 30322 United States Details
Kaiser Permanente Honolulu Hawaii 96819 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
Indiana University School of Medicine Indianapolis Indiana 46202 United States Details
Franciscan St. Francis Health Indianapolis Indiana 46237 United States Details
June E. Nylen Cancer Center Sioux City Iowa 51101 United States Details
The University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Cancer Center of Kansas Wichita Kansas 67214 United States Details
Our Lady of the Lake Physician Group Baton Rouge Louisiana 70808 United States Details
University of Maryland, Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Ann Arbor Hematoloty-Oncology Ann Arbor Michigan 48106 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
North Mississippi Hematology and Oncology Associates Tupelo Mississippi 38801 United States Details
University of Nebraska Medical Center Omaha Nebraska 68130 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
MD Anderson Cooper Cancer Institute Voorhees New Jersey 08043 United States Details
New York Oncology Hematology Albany New York 12208 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
SUNY Upstate Medical University Syracuse New York 13210 United States Details
UNC Chapel Hill Chapel Hill North Carolina 27599 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Medical Center Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
Cancer Centers of the Carolinas Greenville South Carolina 29615 United States Details
Texas Oncology, Amarillo Amarillo Texas 79106 United States Details
Texas Oncology P.A. Austin Texas 78745 United States Details
Texas Oncology, Dallas Dallas Texas 75246 United States Details
Texas Oncology, El Paso El Paso Texas 79902 United States Details
Texas Oncology, Flower Mound Flower Mound Texas 75028 United States Details
Texas Oncology, Fort Worth Fort Worth Texas 76104 United States Details
Texas Oncology, P.A. Houston Texas 77024 United States Details
Cancer Center Network of South Texas San Antonio Texas 78217 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
CAMC Health Education and Research Institute Charleston West Virginia 25304 United States Details
St. Vincent Regional Cancer Center CCOP Green Bay Wisconsin 54301 United States Details
National Cancer Center Goyang-si Gyeonggi-do 410-769 Korea, Republic of Details
Seoul National University Hospital Seoul 110-744 Korea, Republic of Details
Severence Hospital Seoul 120-752 Korea, Republic of Details
Samsung Medical Center Seoul 135-710 Korea, Republic of Details
Asan Medical Center Seoul 138-736 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field